{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:51:27Z","timestamp":1774313487362,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ygyno.2014.08.020","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T14:21:14Z","timestamp":1409062874000},"page":"278-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology \u2014 A prospective comparative study"],"prefix":"10.1016","volume":"135","author":[{"given":"Tine H.","family":"Schnack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie D.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-6998","authenticated-orcid":false,"given":"Lotte","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.08.020_bb0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ejca.2007.12.015","article-title":"Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s","volume":"44","author":"Karim-Kos","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0015","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/00016340902846064","article-title":"Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database","volume":"88","author":"Petri","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0030","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2009.10.003","article-title":"Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review","volume":"75","author":"Pentheroudakis","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10552-010-9525-6","article-title":"Primary peritoneal and ovarian cancers: an epidemiological comparative analysis","volume":"21","author":"Grant","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0045","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"122","author":"Jordan","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.23509","article-title":"Body size and risk of epithelial ovarian and related cancers: a population-based case\u2013control study","volume":"123","author":"Olsen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1438.2006.00590.x","article-title":"Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?","volume":"16","author":"Ayhan","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1525-1438.2001.01027.x","article-title":"Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer","volume":"11","author":"Halperin","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1993.1267","article-title":"Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma","volume":"51","author":"Killackey","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case\u2013control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9098(199807)68:3<173::AID-JSO8>3.0.CO;2-2","article-title":"Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III\u2013IV ovarian papillary serous carcinoma","volume":"68","author":"Piura","year":"1998","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0095","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/gyno.1994.1139","article-title":"Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma","volume":"53","author":"Rosen","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0105","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/cncr.23957","article-title":"Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer","volume":"113","author":"Wethington","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1996.0060","article-title":"Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III\u2013IV ovarian papillary serous carcinoma","volume":"60","author":"Ben-Baruch","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1525-1438.1994.04010043.x","article-title":"Peritoneal adenocarcinoma (serous) of Mullerian type: a subgroup of women presenting with peritoneal carcinomatosis","volume":"4","author":"Fowler","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/gyno.2002.6743","article-title":"Treatment and survival for women with fallopian tube carcinoma: a population-based study","volume":"86","author":"Kosary","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/bjc.1993.394","article-title":"Primary carcinoma of the fallopian tube\u2014a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma","volume":"68","author":"Rosen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","article-title":"Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma\u2014a Gynecologic Oncology Group Study","volume":"89","author":"Bloss","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2007.09.027","article-title":"Serous fallopian tube carcinoma: a retrospective, multi-institutional case\u2013control comparison to serous adenocarcinoma of the ovary","volume":"107","author":"Moore","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0155","doi-asserted-by":"crossref","first-page":"858647","DOI":"10.5402\/2011\/858647","article-title":"Carcinomas of distal fallopian tube and their association with tubal intraepithelial carcinoma: do they share a common \u201cprecursor\u201d lesion? Loss of heterozygosity and immunohistochemical analysis using PAX 2, WT-1, and P53 markers","volume":"2011","author":"Chivukula","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0165","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19950615)75:12<2891::AID-CNCR2820751216>3.0.CO;2-B","article-title":"c-erbB-2 and p53 expression in fallopian tube carcinoma","volume":"75","author":"Lacy","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0170","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0175","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0002-9378(99)70663-0","article-title":"Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening","volume":"180","author":"Karlan","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0185","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2014.08.020_bb0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PGP.0b013e31826a629b","article-title":"Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas","volume":"32","author":"Horn","year":"2013","journal-title":"Int J Gynecol Pathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814012736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814012736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:20:18Z","timestamp":1538284818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814012736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0090825814012736"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.08.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology \u2014 A prospective comparative study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}